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Seaweeds have bioactive compounds of interest in the pharmaceutical industry. In India, seaweeds are 
used exclusively for phycocolloids production and have not yet received consideration as a dietary 
supplement. So, it has become imperative to explore the biomedical potential of seaweeds and promote 
their utilization as a functional food. The seaweeds Turbinaria ornata, Gracillaria crassa and Laurencia 
papillosa, collected from the Tuticorin coast of the Southeast coast of India and selected based on 
preliminary screening, were extracted with acetone and evaluated for antiulcer, wound healing and 
hepatoprotective activities. L. papillosa showed the highest level of gastric protection activity (81%) at 
200 mg/kg, comparable to the standard drug ranitidine (90%). G. crassa followed with 76%. G. crassa 
and L. papillosa, showed marked wound-healing activity. G. crassa at 200 mg/kg, showed a marked 
effect on the serum marker enzymes indicating prominent hepatoprotective activity. The noteworthy 
wound-healing and hepato-protective properties of G. crassa besides anti-ulcer activity next to L. papillosa 
were indicative of its potential for further consideration.
Uniterms: Seaweed/biomedical potential. Seaweed/antiulcer activity. Seaweed/wound-healing. Seaweed/
hepatoprotective activity. Gracilaria crassa/biomedical potential. Turbinaria ornata/biomedical potential. 
Laurencia papillosa/biomedical potential.
Algas marinhas possuem compostos bioativos de interesse para a indústria farmacêutica. Na Índia, as 
algas marinhas são usadas exclusivamente para a produção de ficocolóides e ainda não receberam a 
consideração como um suplemento dietético. Assim, tornou-se imperativo explorar o potencial biomédico 
de algas e promover a sua utilização como alimento funcional. As algas marinhas Turbinaria ornata, 
Gracillaria crassa e Laurencia papillosa, coletadas de Tuticorin, na costa sudeste da Índia, e selecionadas 
com base em triagem preliminar, foram extraídas com acetona e avaliadas quanto à atividade antiúlcera, 
de cicatrização de feridas e de hepatoproteção. L. papillosa mostrou o mais alto nível da atividade de 
proteção gástrica (81%) na dose de 200 mg/kg, comparável ao fármaco padrão, ranitidina (90%). G. 
crassa mostrou atividade de 76%. G. crassa e L. papillosa mostrou atividade martcante na cicatrização 
de feridas. G. Crassa, a 200 mg/kg, mostrou efeito alto sobre o marcador sérico das enzimas, indicando 
atividade hepatoprotetora proeminente. A notável cura de feridas e as propriedades hepatoprotetoras de 
G. Crassa, além da atividade antiúlcera, próxima da L. Papillosa, foram indicativos do seu potencial 
para uma análise mais aprofundada.
Unitermos: Algas marinhas/potencial biomédico. Algas marinhas/atividade antiúlcera. Algas marinhas/
cicatrização de feridas. Algas marinhas/atividade hepatoprotetora. Gracilaria crassa/potencial biomédico. 
Turbinaria ornata/potencial biomédico. Laurencia papillosa/potencial biomédico.
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INTRODUCTION
Traditionally, plants and terrestrial microorganisms 
have been the focus of the search for new drug leads. The 
chemical novelty associated with such natural products 
offer great scope, as scientists are on the lookout for novel 
drug leads to combat the increasing incidence of infectious 
diseases and the development of resistance to existing 
pharmaceuticals. In this context, marine organisms such 
as bacteria, fungi, algae, sponges, soft corals, tunicates, 
molluscs and bryozoans have been shown to be the 
potential sources of novel and biologically active natural 
compounds with numerous pharmacological potentialities 
(Faulkner, 2000). Among them, the seaweeds, that produce 
a wide range of secondary metabolites with broad-
spectrum bioactivity, have immense biomedical potential 
(reviewed by Smit, 2004; El Gamal, 2010) and has been 
used in folk medicine for a variety of remedial purposes 
such as in eczema, gallstone, gout, scrofula, cooling agent 
for fever, menstrual trouble, renal problems, scabies 
(Hoppe, 1979).
A wide range of antibiotic, anti-HIV, anticoagulant, 
anticonvulsant, anti-inflammatory (Dang et al., 2008), 
antineoplastic, wound healing, antiulcer (Nagaoka et al., 
2000), hepatoprotective (Mosaad et al., 2006) and antitumor 
activities for seaweed derived compounds have been 
reported (Lincoln et al., 1991). Seaweeds also assumed 
greater significance as they are rich sources of various types 
of antioxidant compounds (Kuda et al., 2005). The lower 
prevalence of breast and prostate cancer in Japan and China 
has been linked directly to seaweeds that are consumed 
in appreciable quantities in these countries than in North 
America and Europe (Pisani et al., 2002).
The distinctive seaweed resources of the Gulf of 
Mannar, Southeast coast of India are mainly used in 
the production of phycocolloids. The biomedical and 
nutritional potential of the seaweeds has not received 
much attention. So, the seaweeds Turbinaria ornata, 
Gracillaria crassa and Laurencia papillosa, selected 
based on preliminary screening (data not shown), were 
evaluated for pharmacological activities such as antiulcer, 
wound healing and hepatoprotective activities.
MATERIAL AND METHODS
Extraction of seaweed
T h e  s e a w e e d s  Tu r b i n a r i a  o r n a t a  W. R . 
Taylor, 1964 (Phaeophyta: Phaeophyceae: Fucales: 
Sargassaceae), Gracillaria crassa Harvey ex J. Agardh 
1876 (Rhodophyta: Florideophyceae: Gracilariales: 
Gracilariaceae) and Laurencia papillosa (C. Agardh) 
Greville 1830 (Rhodophyta: Florideophyceae: Ceramiales: 
Rhodomelaceae), collected fresh from the Tuticorin coast 
(Lat. 8° 45’N’ long.78°10’E) off the Southeast coast of 
India, were washed thoroughly to remove the adherents 
and air dried in the shade for 24 h. About 100 gms of 
each seaweed was macerated and extracted with 250 mL 
of acetone. Acetone was used based on the preliminary 
screening activity profile (data not shown). The extracts 
were cold steeped overnight at –18 ºC filtered with 
Whatman No.1 filter paper, evaporated, concentrated 
(Becerro et al., 1994; Riguera, 1997) and used in 
pharmacological screening. The yield of extraction was 
2.95 g, 6.34 g and 4.68 g for T. ornata, G. crassa and 
L. papillosa respectively. The dosage of these extracts 
was chosen at random based on preliminary screening 
(data not shown).
Experimental animals
Healthy adult Wistar albino rats of both sexes, 
weighing 100 to 200 g, were used in the experiment. The 
animals were acclimatized to laboratory conditions of 
temperature, humidity (60±5%), 12 h light-dark cycles 
and fed with standard pellet diet and water ad libitum and 
the principles of laboratory animal care were followed. 
The animals were fasted for 16 h, and were provided with 
water alone before the commencement of experiments. 
The experiments were carried out in the Department of 
Pharmacology, S.B. College of Pharmacy, Sivakasi and 
the necessary permission for the experiments was obtained 
from institutional ethics committee (Approval No. IAEC/
CPCSEA/SBCP/2006-2007/06).
Antiulcer activity
In the antiulcer assay (Shay et al., 1945; Suzuki et 
al., 1976), the albino rats were divided into eight groups 
of four individuals each. The Group I received normal 
saline and served as negative control. Group II received 
50 mg/kg p.o. of ranitidine as standard drug. Group III 
and IV received a Turbinaria ornata extract, Group V 
and Group VI were given Gracilaria crassa extract and 
Group VII and VIII were treated with Laurencia papillosa 
extract, dissolved in normal saline, at a dosage of 100 and 
200 mg/kg p.o. All the animals received test extracts daily 
for three days and on the fourth day, a midline incision 
was made under anesthesia with ether and the stomach 
was exposed for pylorus ligation (Shay et al., 1945). The 
abdominal opening was closed by suture and the rat was 
not allowed to sleep.
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The animals were deprived of water during the post-
operative period and were sacrificed after 4 h. The stomach 
was carefully dissected out and gastric juice was collected 
and centrifuged at 3000 rpm for 30 minutes. The total 
volume of gastric juice, its pH, free and total acidity of 
gastric secretion, sodium and potassium ion concentration 
in gastric juice were estimated. The free and total acidities 
of the supernatant were calculated by titration with 0.1 N 
NaOH (Kulkarni, 1999). The stomach was incised along 
the greater curvature and pinned on a soft wooden board 
for evaluation of the ulcerated area and the ulcer index in 
the glandular stomach region was measured as Normal 
colored stomach-0, Red colouration-0.5, Spot ulcers-1, 
Haemorrhagic streaks-1.5, Surface ulcer-2, Deep ulcer-3, 
Perforation-4 and the mean ulcer score for each animal 
were expressed as ulcer index (Ganguli, Bhatnagar, 1973).
The percentage of ulcer inhibition was calculated by 
the following formula: 
Wound healing activity
Eight groups of Wistar albino rats, with four animals 
in each group, were anesthetized with ether and the 
animals were depilated on the back. One excision wound 
was inflicted by cutting away a 500 mm2 full thickness 
of skin from the depilated area. Then, this wound was 
undressed to the open environment. A commercial simple 
ointment [Hittboss 50 g (wool fat: 2.5 g, hard paraffin: 
2.5 g, cetostearyl alcohol: 2.5 g, white soft paraffin: 
42.5 g)] was formulated with 100 and 200 mg/kg of 
the seaweed Turbinaria ornata, Gracilaria crassa and 
Laurencia papillosa extracts. Seaweed extracts were 
prepared with 5% w/w ointment. Group I, the control, 
received a simple ointment base and the Group II was 
treated with standard povidone iodine ointment (5% w/w).
The test ointment of Turbinaria ornata was applied 
to Group III and IV animals and Group V and VI were 
treated with Gracilaria crassa ointment and Group VII 
and VIII with Laurencia papillosa based ointment. All the 
wounds in rats were traced using graph paper on the day 
of wounding. Then the standard drug and test ointments 
were applied daily till the wound was completely healed. 
The progressive changes in wound area were monitored 
planimetrically by tracing the wound margin on graph 
paper every alternate day, which gave an indication 
of the rate of wound healing activity. The number of 
days required for healing of the wound was determined 
(Chatterjee, Chakaravorty, 1993).
Hepatoprotective activity
Thirty six albino rats were randomly divided into 
nine groups consisting of four animals each. The Group 
I, which served as non-intoxicated control, was treated 
with normal saline. Liver damage was induced in other 
groups of animals by orally treating with rifampicin 
(1000 mg/kg). The Group II served as intoxicated control 
and received no test extracts. The Group III received 
standard drug silymarin at 100 mg/kg and Groups IV 
and V received a Turbinaria ornata extract at 100 and 
200 mg/kg, p.o. The Groups VI and VII animals were 
treated with Gracilaria crassa extracts and Groups VIII 
and Group IX animals Laurencia papillosa extract at a 
dose level of 100 and 200 mg/kg p.o respectively. All 
the test seaweed extracts, dissolved in normal saline, 
and silymarin were administered four times with 12 h 
intervals. After 48 h of Rifampicin administration, blood 
was collected from all the groups of animals by puncturing 
retro orbital plexus after anesthetizing with chloroform. 
The blood samples were allowed to clot for 45 minutes 
at room temperature and the serum was separated by 
centrifugation at 2500 rpm at 37 oC for 10 min for the 
assessment of biochemical parameters of serum glutamic 
oxaloacetic transaminase (SGOT), serum glutamic pyruvic 
transaminase (SGPT) and alkaline phosphatase, direct and 
indirect and total bilirubin (Kurma, Mishra, 1997).
Statistical analysis
The values were expressed as mean ± SD of four 
replicates for each experiment. Student’s t-test indicated 
the significance of the experimental results compared to 
control and P<0.05 was considered as significant.
RESULTS
When compared to the Group I negative control, 
almost all the three extracts showed antiulcer activity 
(Figure 1 and Table I). The acetone extract of Gracilaria 
crassa and Laurencia papillosa significantly reduced 
the total volume of gastric juice, free and total acidity of 
gastric secretion and Na+ content of gastric juice at 200 
mg/kg concentration. The increase in pH level and K+ 
content indicated the good antiulcer activity against gastric 
pyloric ulcers in rats. The percentage of antiulcer activity 
of seaweed L. papillosa and G. crassa at 200 mg/kg 
were comparable to the performance of the standard drug 
Ranitidine. When compared to control, the activity of 
both the extracts was significant (P<0.05), except that 
of K value of G. crassa at 100 mg/kg. Though T. ornata 
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showed good activity, it was low when compared to the 
other two seaweeds. The results indicated the highest level 
of gastric protection activity by L. papillosa extract at all 
concentrations.
G. crassa and L. papillosa, showed marked 
wound-healing activity when compared to that of 
the reference standard and a control group of albino 
rats (Figure 2). The wound healing activity of the 
G. crassa extract at the concentration of 200 mg/kg 
(249±0.8 mm2) was comparable with that of standard 
ointment (243±1.7 mm2) on the 6th day of the experiment. 
The reduction in wound area was significant in rats 
treated with G. crassa (9±6.3 mm2) and L. papillosa 
(10±2.5 mm2) at the concentration of 200 mg/kg when 
TABLE I - Antiulcer activity of acetone extract of seaweed Turbinaria ornata, Gracilaria crassa and Laurencia papillosa against 
pylorus ligation induced gastric ulcer: Acidity, Ulcer score and % of Ulcer inhibition
Treatment Group Dose (mg/kg)
Free acidity 
mEq/L
Total acidity 
mEq/L Ulcer score
% of ulcer 
inhibition
Control I - 19.22±0.6 47.42±2.7 2.57±0.3 -
Ranitidine II 50 7.67±0.4* 22.24±1.0* 0.25±0.3* 90.27
Turbinaria ornata III 100 17.78±0.4* 41.92±0.5* 1.75±0.3* 31.91
IV 200 13.82±0.7* 36.59±0.5* 1.12±0.3* 56.42
Gracilaria crassa V 100 14.41±0.5* 36.41±0.8* 1.25±0.3* 51.36
VI 200 8.39±0.8* 23.12±1.3* 0.62±0.3* 75.88
Laurencia papillosa VII 100 11.57±0.4* 25.15±1.1* 0.75±0.3* 70.82
VIII 200 7.11±0.1* 20.70±0.4* 0.5±0.3* 80.55
(values: mean±SD of four replicates) (*P<0.05 compared to control)
FIGURE 1 - Antiulcer activity of acetone extract of seaweed Turbinaria ornata, Gracilaria crassa and Laurencia papillosa against 
pylorus ligation induced gastric ulcer: Gastric Volume, pH, Na and K (Values: mean±SD of four replicates; *P<0.05 compared to 
control; C-Control; R-Ranitidine; TO-Turbinaria ornata; GC-Gracilaria crassa; LP-Laurencia papillosa; I-VIII - Animal Groups; 
R-II-50 mg/kg; TO-III, GC-V & LP-VII -100 mg/kg; TO-IV, GC-VI & LP-VIII-200 mg/kg).
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FIGURE 2 - Wound healing activity of seaweed Turbinaria ornata, Gracilaria crassa and Laurencia papillosa acetone extracts. 
(Values: mean±SD of four replicates; *P<0.05 compared to control; C-Control; PI-Povidone Iodine ointment (5% w/w); TO-
Turbinaria ornata; GC-Gracilaria crassa; LP-Laurencia papillosa; I-VIII - animal groups; TO-III, GC-V, LP-VII-100 mg/kg; 
TO-IV, GC-VI, LP-VIII-200 mg/kg).
compared to the positive control group of animals 
(5±1.6 mm2) on the 18th day and on the 20th day, the two 
extracts at the same concentration showed complete 
healing in comparison with standard drug. The T. ornata 
extract exhibited lowest reduction in the wound area at 
both concentrations when compared to standard drug on 
the 20th day. The activities of all extracts were significant 
(P<0.05) when compared to control.
In the hepatoprotective activity assay, there was a 
significant increase in serum GOT, GPT, ALP and bilirubin 
levels in toxicated Group II than the normal control 
Group I (Figure 3 and Table II) and the seaweed extracts 
showed reduction in their elevated levels. 
G. crassa showed a marked effect on the serum 
marker enzymes at 200 mg/kg dose when compared to that 
of standard drug, indicating the prominent hepatoprotective 
activity. The SGPT level was prominently reduced by all 
extract concentrations than that by standard drug (Group 
III). The L. papillosa (200 mg/kg) reduced the level of 
bilirubin equal to that of the standard drug and T. ornata 
showed equivalent activity to that of the standard drug 
in the reduction of direct bilirubin. The activities of the 
extracts were dose dependent and significant (P<0.05) 
when compared to negative control Rifampicin. 
DISCUSSION
G. crassa possesses alkaloids, flavonoids, saponins, 
tannins and cardiac glycosides (Jeyaseelan et al., 2012). 
The higher percentage of antiulcer activity observed in L. 
papillosa and G. crassa against gastric and pyloric ulcers 
in rats could be due to the terpenoid compounds (Kuniyoshi 
et al., 2005) as terpenoid compounds are effective antiulcer 
agents because they protect the mucosa from the acid effects 
by selectively inhibiting prostaglandin PGF2 (Aguwa, 
Okunji, 1986). The report that Gracilaria spp. has been 
used in the treatment of stomach disorders (Trono, 1999) 
and the usefulness of carrageenan in ulcer therapy (De 
Almeida et al., 2011), substantiated the antiulcer activity 
of G. crassa in the present study. Also, the sulfated algal 
polysaccharides (Silva et al., 2011) in the seaweeds may 
provide an effective protection against gastric damage. The 
fats play a buffering role in reducing and neutralizing the 
gastric juice and the reported presence of fatty acids in anti-
ulcer compounds isolated from G. verrucosa (Sakagami 
et al., 1992) substantiated the anti-ulcer activity in G. 
crassa. And, the presence of polyunsaturated fatty acids in 
Gracilaria species (Vasanthi et al., 2012), the precursors 
of prostaglandins, which increase the mucosal resistance, 
K. A. Senthil, A. Murugan674
might be the responsible factor for anti-ulcer activity of G. 
crassa.
The oxygen-derived free radicals play an important 
role in the pathogenesis of the injury to various tissues, 
including the digestive system (Boonchum et al., 2012). 
The species of the genus Gracilaria contain abundant 
amino acids, fatty acids, vitamins, minerals, polyphenolic 
compounds and carbohydrates (Marinho-Soriano, Bourret, 
2005; Yangthong et al., 2009; De Almeida et al., 2011) 
which might play a role in the defense against oxidative 
tissue damage caused by ulceration in the stomach. The 
report on the health promoting properties of the genus 
Gracilaria seaweed extracts especially antioxidative 
properties (Ganesan et al., 2008; Yangthong et al., 2009; 
Vijayavel, Marinez, 2010; Souza et al., 2011) substantiated 
the observation in G. crassa. The fact that Gracilaria 
TABLE II - Hepatoprotective activity of seaweed Turbinaria ornata, Gracilaria crassa and Laurencia papillosa acetone extracts
Treatment Group Dose (mg/kg)
Bilirubin Direct 
(mg/dL)
Bilirubin Indirect 
(mg/dL)
Bilirubin 
(mg/dL)
Control I -- 0.5±0.1 1±0.3 1.6±0.3
Rifampicin II 1000 1.8±0.3 3.7±0.6 5.6±0.9
Silymarin III 100 0.6±0.2* 0.9±0.1* 2.0±0.3*
Turbinaria ornata IV 100 1.1±0.2* 1.9±0.2* 4.0±0.8*
V 200 0.5±0.2* 1.3±0.3* 2.3±0.4*
Gracilaria crassa VI 100 1.6±0.2 2.0±0.2* 3.9±0.7*
VII 200 0.8±0.1* 1.3±0.2* 2.1±0.3*
Laurencia papillosa VIII 100 1.0±0.3* 1.9±0.2* 3.0±0.4*
IX 200 0.6±0.2* 1.1±0.3* 1.7±0.3*
(values: mean±SD of four replicates) (*P<0.05 compared to rifampicin group)
FIGURE 3 - Hepatoprotective activity of seaweed Turbinaria ornata, Gracilaria crassa and Laurencia papillosa acetone extracts: 
SGOT, SGPT and alkaline phosphatase. (Values: mean±SD of four replicates; *P<0.05 compared to Rifampicin group; C-Control; 
R-Rifampicin-1000 mg/kg; S-Silymarin-100 mg/kg; TO-Turbinaria ornata; GC-Gracilaria crassa; LP-Laurencia papillosa; I-IX-
Group of animals; TO-IV, GC-VI, LP-VIII - 100 mg/kg; TO-V, GC-VII, LP-IX-200 mg/kg).
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species possess anti-inflammatory compounds (Dang et 
al., 2008; Coura et al., 2011) adds value to antiulcer and 
wound healing activities in G. crassa.
Brown algae possesses polysaccharides fucoidan, 
laminaran, cellulose, alginates and mannitol and algal 
fucans, galactans and alginates have been shown to 
possess anticoagulant, anticancer and hypocholesterolemic 
activities (Lordan et al., 2011). Fucoidans are reported to 
have an effect on the inflammatory and immune systems 
(Pomin, Mourao, 2008) and laminarin has been identified 
as a modulator of intestinal metabolism through its effects 
on mucus composition, intestinal pH and short chain fatty 
acid production (Deville et al., 2007). The activity in T. 
ornata corresponds to the presence of polysaccharides with 
anti-ulcer activity (Shibata et al., 2003) and high phenolic 
levels with antioxidant and antibacterial activities (Zubia et 
al., 2008). The present study coincided with the report of 
Boonchum et al. (2012) that aqueous extract of T. conoides 
reduced gastric ulceration in the range of 50.98 - 99.85% at 
500 mg.kg-1 dosage. Comparatively, in the present study, the 
observed activity at 200 mg/kg dosage was higher (56%). 
The activity in T. ornata was further substantiated by the 
free radical scavenging property and anti-inflammatory 
potential (Ananthi et al., 2011). The cytoprotective nature of 
aqueous extract of the brown algae against gastric mucosal 
erosions has been substantiated with a near normal value 
of proteins (Balaji, Raghavendran et al., 2004). Also, the 
presence of halogenated and non halogenated terpenoids 
(Suzuki, Kurosawa, 1979) in the seaweeds could be 
attributed to their wound healing capacity. It could be 
deduced that a combination of factors mentioned above 
might be responsible for the untiulcer and wound healing 
activities of the three algae.
When the liver cells get damaged as a result of 
introduction of infectious agents or chemicals, the serum 
levels of GPT and GOT tend to increase significantly 
(Recknagel, 1967) as observed in the present study. 
Similarly, elevations of creatinine and bilirubin have been 
reported in the acetaminophen induced hepato-toxicity 
(Ellenhorn et al., 1997). The prominent activity in G. 
crassa at 200 mg/kg dosage was substantiated by similar 
elevated levels of total bilirubin, SGOT, SGPT, LDH 
and ALP in aflatoxin B1 intoxicated rats and restoration 
to normal level in the rats treated with aqueous extract 
(250 mg kg-1 body weight) of marine algae G. corticata 
(Manoharan et al., 2008). The hepatoprotective activity 
reported in G. edulis against liver injury induced by 
D-Galactosamine/endotoxin in rats (Sathivel et al., 2003) 
holds good for the present observation.
The reported chemoprotective effect of L. obtusa and 
Caulerpa prolifera extracts, collected from the Egyptian 
coast of the Red Sea, against AFB1-initiated liver change 
in rats (Mosaad et al., 2006) substantiated the observed 
higher activity in L. papillosa. The hepatoprotective nature 
of the brown seaweeds Sargassum polycystem and that 
of Ecklonia stolonifera against acetaminophen induced 
hepatic damage in rats (Balaji Raghavendran et al., 2004) 
and tacrine-induced cytotoxicity in Hep G2 cells (Kim 
et al., 2005) holds well for the activity in T. ornata. The 
present observation of dose dependent activity in the three 
seaweed extracts coincided with the observation of Wong 
et al. (2000) in Myagropsis myagroides and Sargassum 
henslowianum.
Vijayabaskar and Shyamala (2011) reported a 
highest polyphenolic content of 43.72 ± 1.63 mg gallic 
acid equivalents (GAE)/g extract in T. ornata from 
Gulf of Mannar. Hence, the activity in T. ornata could 
be attributed to the polyphenolic derivatives (Zubia et 
al., 2008; Thomas, Kim, 2011). Also, in pharmaceutical 
field, alginates have been used to treat wounds and 
gastric ulcers for many years (Nagaoka et al., 2000). 
Calcium alginate has been reported to have both healing 
and preventive effects on CCl4 induced hepatotoxic 
damages in rats, suggesting that the ameliorative effects 
of calcium alginate may be related to its antioxidant 
properties (Khotimchenko, Khotimchenko, 2004) of 
brown seaweeds. It could be deduced that the compounds 
which give protection against liver plasma membrane 
alteration or promote cellular mitosis action for the repair 
of the liver cells (Wong et al., 2000) may be responsible 
for the hepatoprotective activity of the seaweeds.
Seaweeds produce compounds like carotenoids, 
terpenoids, xanthophylls, chlorophyll, vitamins, saturated 
and polyunsaturated fatty acids, amino acids, acetogenins, 
antioxidants such as polyphenols, alkaloids, halogenated 
compounds and polysaccharides such as agar, carrageenan, 
proteoglycans, alginate, laminaran, rhamnan sulfate, 
galactosyl glycerol and fucoidan (De Almeida et al., 
2011) and hence, will be of immense help to humanity. 
The antiulcer activity in seaweeds assumes significance 
considering the fact that proton pump inhibitors and 
selective H2 receptor blockers, used in ulcer treatment, 
have side effects with 70% possibility of recurrence of 
stopping the same (Sachs et al., 2002). The review of 
the bioactive metabolites of alga belonging to the genus 
Gracilaria (De Almeida et al., 2011), the report that a 
Laurencia terpenoid extract from the red alga Laurencia 
tristicha could improve antioxidative and decrease DNA 
damage effectively and safe to be taken orally (Liang 
et al., 2007), the postulation that L. undulata could be 
used as adjuvant therapeutic materials for patients with 
bronchial asthma (Jung et al., 2009) and the fact that the 
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brown algae (Phaeophyceae) has normally never been 
associated with toxin production and lack of signs of 
toxicity nor deaths when rats were administered with 
5000 mg/kg-1 of the aqueous extract of T. conoides during 
14 days of observation (Boonchum et al., 2012) implied 
that the three screened seaweeds in the present study 
could be of immense value in antiulcer, wound healing 
and hepatoprotective functionality.
CONCLUSIONS
The acetone extracts of seaweeds Gracilaria 
crassa, Laurencia papillosa and Turbinaria ornata 
showed antiulcer, wound healing and hepatoprotective 
activities. Among them, G. crassa was significant as it 
showed prominent and noteworthy wound healing and 
hepatoprotective activities besides showing good antiulcer 
activity next to Laurencia papillosa. G. crassa could be a 
potential candidate of biomedical importance.
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